Form 8-K - Current report:
SEC Accession No. 0001193125-25-132150
Filing Date
2025-05-30
Accepted
2025-05-30 16:18:52
Documents
12
Period of Report
2025-05-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d65075d8k.htm   iXBRL 8-K 34156
  Complete submission text file 0001193125-25-132150.txt   147590

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA etnb-20250528.xsd EX-101.SCH 2845
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20250528_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20250528_pre.xml EX-101.PRE 11258
14 EXTRACTED XBRL INSTANCE DOCUMENT d65075d8k_htm.xml XML 3634
Mailing Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 251011225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)